These studies collectively confirm that various epigenetic mechanisms regulate the expression of multiple NKG2D ligand in different cancer cell types, and modulating these mechanisms offers the possibility of enhancing NK-cell based therapy for cancer treatment. The gene discussed is KLRK1; the disease is cancer.